DiagnaMed Develops AI-Driven Brain Health Solutions
![DiagnaMed Develops AI-Driven Brain Health Solutions](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
DiagnaMed Expands with Drug and Clinical Research AI Platform
Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE Brain Health AI.
Accelerating clinical trial development and discovering potential novel treatments for neurological, psychiatric, and infectious diseases.
DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, announces it is expanding the use of its novel BRAIN AGE Brain Health AI Platform through leveraging its electroencephalograph (EEG) data from research studies and future data collection, and applying it to build a potential drug discovery and clinical research AI platform. EEG provides a real-time readout of brain-wave activity in different brain regions and can measure a drug effect on the brain. BRAIN AGE has the potential to accelerate patient recruitment for clinical trials, data analysis, drug development go/no-go decisions, and new treatment options for neurological, psychiatric, and infectious diseases.
Clinical Validation of BRAIN AGE Brain Health AI Platform
BRAIN AGE Brain Health AI estimates brain age by recording brain-wave activity from multiple brain regions and calculating the data with a proprietary machine-learning model. Certain drugs acting on the brain can generate a consistent EEG effect and produce models useful for developing novel drug analogs and potential drug repurposing ideas. In studying the effects of drugs on the brain via EEG, researchers can classify and identify drugs according to their mechanism of action on brain activity.
BRAIN AGE Brain Health AI can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram headset and calculating the data with a proprietary machine-learning model. In addition, BRAIN AGE Brain Health AI can assess if a person has a healthy brain or is in the early stages of cognitive decline. Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability, and performance functions. Individuals can seek out personalized diagnostics and interventions, such as medication or lifestyle changes, that may help decrease cognitive decline development or progression.
Research and Development Advances
In a peer-reviewed paper published in Frontiers in Neuroergonomics, titled "Brain-age estimation with a low-cost EEG-headset: effectiveness and implications for large-scale screening and brain optimization", BRAIN AGE was highlighted regarding its clinical potential. It was noted that the platform can be used as a relatively inexpensive way to screen large numbers of people for vulnerability to age-related cognitive decline. Regular screenings can help assess changes over time, test the effectiveness of medications, and evaluate lifestyle modifications for enhancing brain performance.
About DiagnaMed
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a healthcare technology company focused on brain health using AI. DiagnaMed is commercializing BRAIN AGE Brain Health AI Platform, a world-first consumer brain health and wellness AI solution that estimates brain age and provides a brain health score. Visit DiagnaMed.com.
Contact Information
For more information, please contact:
Fabio Chianelli
Chairman and CEO
DiagnaMed Holdings Corp.
Tel: 416-800-2684
Email: info@diagnamed.com
Website: www.diagnamed.com
Frequently Asked Questions
What is the BRAIN AGE platform?
The BRAIN AGE platform is an AI-driven tool that estimates brain age and provides insights into brain health based on EEG data.
How does the BRAIN AGE platform work?
The platform records brain-wave activity using a low-cost EEG headset and employs machine learning to analyze the data.
What types of diseases can the platform help research?
It aims to discover treatments for neurological, psychiatric, and infectious diseases by improving clinical trial efficiency.
What is the significance of EEG data?
EEG data provides a real-time readout of brain activity, allowing researchers to assess the effects of drugs and identify mechanisms of action.
How can individuals benefit from the BRAIN AGE platform?
Individuals can seek personalized diagnostics and interventions that may help mitigate cognitive decline and enhance overall brain health.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/